BlueOcean Global Corp., a medical device company focused on limb preservation and complex reconstruction, today announced U.S ...
Looser regulations around consumer-grade wearable devices could be a "path to ROI" for health systems—or a "double-edged ...
FDA commissioner Marty Makary said it would be “magical” for consumers to see prescription drugs on pharmacy shelves instead ...
News-Medical.Net on MSN
AI-designed NLRP3 inhibitor receives FDA clearance for Parkinson disease trials
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S.
When the Food and Drug Administration announced that the agency would be removing the black-box warning from hormone ...
Franklin Lakes, New Jersey Saturday, January 17, 2026, 10:00 Hrs [IST] ...
Insilico Medicine and Qilu Pharmaceutical Group announced a strategic collaboration to jointly develop small-molecule inhibitors for cardiometabolic diseases, combining Insilico’s generative AI–driven ...
Priyanka Chigurupati, Executive Director of Granules India, said that funds raised through warrants and primary issuance will be used to strengthen the balance sheet and support growth in complex ...
Americans cannot rely on the Food & Drug Administration (FDA) to guarantee that medical devices are safe, and a recent Government Accountability ...
The Print on MSN
Health ministry eases drug trial rules. Test licences scrapped, CDSCO approval timelines cut by half
Under earlier rules, drugmakers had to get a test licence from CDSCO to manufacture small quantities of drugs for research, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results